ADVISORY COMMITTEE WILL ADDRESS RISK COMMUNICATION
The FDA will form a new advisory committee of outside specialists to advise the agency on how to inform the public about the risks and benefits of medicines and medical devices. The Risk Communication Advisory Committee will:
- Help the FDA better understand the communication needs and priorities of the general public
- Advise the FDA on the development of strategic plans to communicate product risks and benefits
- Make recommendations to the FDA based on current research about crafting risk and benefit messages, as well as how to effectively communicate specific product information to vulnerable audiences
The committee "will bring together a broad range of experts and views to help improve the FDA's communication of the science-based information about product risks and benefits that the public needs to make informed decisions."